Applied Finance Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Buy
+722
New +$405K 0.03% 168
2025
Q4
Sell
-1,251
Closed -$799K 269
2025
Q3
$799K Sell
1,251
-455
-27% -$276K 0.06% 131
2025
Q2
$915K Sell
1,706
-311
-15% -$149K 0.06% 132
2025
Q1
$847K Buy
2,017
+466
+30% +$202K 0.06% 134
2024
Q4
$641K Buy
1,551
+68
+5% +$29.8K 0.03% 166
2024
Q3
$749K Hold
1,483
0.03% 159
2024
Q2
$723K Buy
+1,483
New +$745K 0.03% 133

Other funds holding IDXX

Applied Finance Capital Management's IDXX Position: Q2 2026 in Review

Applied Finance Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 722 shares worth $380K. The stake represents 0.03% of the portfolio and ranks #168 among its holdings. This is a return to the name: Applied Finance Capital Management previously reported a position in IDXX as recently as Q3 2025.

Applied Finance Capital Management first reported a position in IDXX in Q2 2024 and has held it in 7 quarters since. The position peaked at $915K in Q2 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Applied Finance Capital Management held 722 shares of Idexx Laboratories worth $380K as of Q2 2026.
  • Idexx Laboratories was a new Applied Finance Capital Management position in Q2 2026.
  • Idexx Laboratories made up 0.03% of Applied Finance Capital Management's portfolio in Q2 2026, its #168 holding.
  • Applied Finance Capital Management first reported a position in Idexx Laboratories in Q2 2024 and has held it in 7 quarters since.
  • Applied Finance Capital Management's Idexx Laboratories position peaked at $915K in Q2 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.